Two Indian nationals have been indicted by a US federal grand jury for allegedly smuggling and selling counterfeit Ozempic, a weight-loss drug, between July 2023 and April 2024. One defendant, Swapnadip Roy, was extradited from Italy and pleaded not guilty; the other, Vicky Ramancha, remains at large. The defendants obtained the fake medication in China and sold it to US distributors at discounted prices despite an…
US says two Indian nationals indicted in counterfeit Ozempic smuggling scheme (this article)